Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.
Anti-HER2 immunoliposomes produced enhanced antitumor efficacy via targeted delivery.
Anti-HER2 immunoliposomes produced enhanced antitumor efficacy via targeted delivery.
Such an indicator would be useful in selection of those node-negative patients with breast carcinoma who are at high risk for having occult metastasis at presentation. These pat...
h-index: Number of publications with at least h citations each.